nodes	percent_of_prediction	percent_of_DWPC	metapath
Methamphetamine—Lacosamide—epilepsy syndrome	0.355	1	CrCtD
Methamphetamine—ADRA2A—epilepsy syndrome	0.0688	0.435	CbGaD
Methamphetamine—SLC6A4—epilepsy syndrome	0.0525	0.332	CbGaD
Methamphetamine—MAOB—Zonisamide—epilepsy syndrome	0.0391	0.432	CbGbCtD
Methamphetamine—CYP2D6—epilepsy syndrome	0.0369	0.233	CbGaD
Methamphetamine—Isocarboxazid—Lacosamide—epilepsy syndrome	0.0342	0.131	CrCrCtD
Methamphetamine—MAOA—Zonisamide—epilepsy syndrome	0.0307	0.34	CbGbCtD
Methamphetamine—Lacosamide—Felbamate—epilepsy syndrome	0.0272	0.104	CrCrCtD
Methamphetamine—Phenacemide—Felbamate—epilepsy syndrome	0.0184	0.0707	CrCrCtD
Methamphetamine—Lisdexamfetamine—Lacosamide—epilepsy syndrome	0.0184	0.0707	CrCrCtD
Methamphetamine—Phenformin—Lacosamide—epilepsy syndrome	0.0184	0.0707	CrCrCtD
Methamphetamine—Nateglinide—Lacosamide—epilepsy syndrome	0.0164	0.063	CrCrCtD
Methamphetamine—Aspartame—Lacosamide—epilepsy syndrome	0.0156	0.0599	CrCrCtD
Methamphetamine—SLC22A5—Valproic Acid—epilepsy syndrome	0.0154	0.171	CbGbCtD
Methamphetamine—Bethanidine—Lacosamide—epilepsy syndrome	0.0142	0.0545	CrCrCtD
Methamphetamine—L-Phenylalanine—Felbamate—epilepsy syndrome	0.0136	0.0522	CrCrCtD
Methamphetamine—Mephentermine—Lacosamide—epilepsy syndrome	0.0136	0.0522	CrCrCtD
Methamphetamine—Phenelzine—Lacosamide—epilepsy syndrome	0.0131	0.0501	CrCrCtD
Methamphetamine—Phentermine—Lacosamide—epilepsy syndrome	0.0126	0.0482	CrCrCtD
Methamphetamine—Phenacemide—Lacosamide—epilepsy syndrome	0.0106	0.0406	CrCrCtD
Methamphetamine—Amphetamine—Lacosamide—epilepsy syndrome	0.0103	0.0394	CrCrCtD
Methamphetamine—Dextroamphetamine—Lacosamide—epilepsy syndrome	0.0103	0.0394	CrCrCtD
Methamphetamine—L-Phenylalanine—Lacosamide—epilepsy syndrome	0.00781	0.03	CrCrCtD
Methamphetamine—Benzphetamine—Phenytoin—epilepsy syndrome	0.00598	0.023	CrCrCtD
Methamphetamine—CYP2D6—Propofol—epilepsy syndrome	0.00516	0.0571	CbGbCtD
Methamphetamine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00156	0.0577	CbGeAlD
Methamphetamine—MAOA—locus ceruleus—epilepsy syndrome	0.00144	0.0531	CbGeAlD
Methamphetamine—SLC18A2—telencephalic ventricle—epilepsy syndrome	0.00121	0.0448	CbGeAlD
Methamphetamine—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000919	0.0339	CbGeAlD
Methamphetamine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.00083	0.0306	CbGeAlD
Methamphetamine—SLC18A2—ganglion—epilepsy syndrome	0.000756	0.0279	CbGeAlD
Methamphetamine—SLC6A3—ganglion—epilepsy syndrome	0.000572	0.0211	CbGeAlD
Methamphetamine—SLC18A1—head—epilepsy syndrome	0.000568	0.021	CbGeAlD
Methamphetamine—SLC18A1—nervous system—epilepsy syndrome	0.000539	0.0199	CbGeAlD
Methamphetamine—SLC22A3—tongue—epilepsy syndrome	0.000533	0.0197	CbGeAlD
Methamphetamine—SLC6A4—ganglion—epilepsy syndrome	0.000524	0.0193	CbGeAlD
Methamphetamine—SLC18A1—central nervous system—epilepsy syndrome	0.000519	0.0191	CbGeAlD
Methamphetamine—TAAR1—nervous system—epilepsy syndrome	0.000507	0.0187	CbGeAlD
Methamphetamine—MAOB—ganglion—epilepsy syndrome	0.000498	0.0184	CbGeAlD
Methamphetamine—TAAR1—central nervous system—epilepsy syndrome	0.000488	0.018	CbGeAlD
Methamphetamine—SLC6A2—ganglion—epilepsy syndrome	0.000461	0.017	CbGeAlD
Methamphetamine—SLC6A3—hindbrain—epilepsy syndrome	0.000434	0.016	CbGeAlD
Methamphetamine—MAOA—ganglion—epilepsy syndrome	0.000425	0.0157	CbGeAlD
Methamphetamine—SLC18A1—brain—epilepsy syndrome	0.000412	0.0152	CbGeAlD
Methamphetamine—SLC6A4—hindbrain—epilepsy syndrome	0.000397	0.0147	CbGeAlD
Methamphetamine—MAOB—hindbrain—epilepsy syndrome	0.000378	0.0139	CbGeAlD
Methamphetamine—SLC18A2—brainstem—epilepsy syndrome	0.000329	0.0121	CbGeAlD
Methamphetamine—MAOA—hindbrain—epilepsy syndrome	0.000322	0.0119	CbGeAlD
Methamphetamine—SLC18A2—forebrain—epilepsy syndrome	0.000317	0.0117	CbGeAlD
Methamphetamine—SLC18A2—telencephalon—epilepsy syndrome	0.000292	0.0108	CbGeAlD
Methamphetamine—SLC6A3—brainstem—epilepsy syndrome	0.000249	0.00917	CbGeAlD
Methamphetamine—SLC6A3—forebrain—epilepsy syndrome	0.00024	0.00885	CbGeAlD
Methamphetamine—SLC18A2—medulla oblongata—epilepsy syndrome	0.000229	0.00845	CbGeAlD
Methamphetamine—SLC6A4—brainstem—epilepsy syndrome	0.000228	0.0084	CbGeAlD
Methamphetamine—SLC6A3—telencephalon—epilepsy syndrome	0.000221	0.00814	CbGeAlD
Methamphetamine—SLC6A4—forebrain—epilepsy syndrome	0.00022	0.00811	CbGeAlD
Methamphetamine—MAOB—brainstem—epilepsy syndrome	0.000217	0.00799	CbGeAlD
Methamphetamine—Phenacemide—SCN1A—epilepsy syndrome	0.000211	0.112	CrCbGaD
Methamphetamine—SLC18A2—midbrain—epilepsy syndrome	0.000209	0.00773	CbGeAlD
Methamphetamine—MAOB—forebrain—epilepsy syndrome	0.000209	0.00771	CbGeAlD
Methamphetamine—SLC6A4—telencephalon—epilepsy syndrome	0.000202	0.00746	CbGeAlD
Methamphetamine—SLC6A2—brainstem—epilepsy syndrome	0.000201	0.0074	CbGeAlD
Methamphetamine—Insomnia—Rufinamide—epilepsy syndrome	0.000195	0.0039	CcSEcCtD
Methamphetamine—Dizziness—Amobarbital—epilepsy syndrome	0.000194	0.00387	CcSEcCtD
Methamphetamine—Euphoric mood—Gabapentin—epilepsy syndrome	0.000194	0.00386	CcSEcCtD
Methamphetamine—SLC6A2—forebrain—epilepsy syndrome	0.000194	0.00714	CbGeAlD
Methamphetamine—Psychotic disorder—Valproic Acid—epilepsy syndrome	0.000193	0.00385	CcSEcCtD
Methamphetamine—MAOB—telencephalon—epilepsy syndrome	0.000192	0.00709	CbGeAlD
Methamphetamine—CYP2D6—hindbrain—epilepsy syndrome	0.000192	0.00707	CbGeAlD
Methamphetamine—Dyspepsia—Rufinamide—epilepsy syndrome	0.00019	0.0038	CcSEcCtD
Methamphetamine—Constipation—Phenobarbital—epilepsy syndrome	0.000188	0.00376	CcSEcCtD
Methamphetamine—Aspartame—TRPV1—epilepsy syndrome	0.000187	0.0999	CrCbGaD
Methamphetamine—Tremor—Propofol—epilepsy syndrome	0.000187	0.00374	CcSEcCtD
Methamphetamine—Dizziness—Primidone—epilepsy syndrome	0.000187	0.00373	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000187	0.00372	CcSEcCtD
Methamphetamine—Constipation—Rufinamide—epilepsy syndrome	0.000185	0.00369	CcSEcCtD
Methamphetamine—MAOA—brainstem—epilepsy syndrome	0.000185	0.00682	CbGeAlD
Methamphetamine—Headache—Amobarbital—epilepsy syndrome	0.000184	0.00367	CcSEcCtD
Methamphetamine—Agitation—Propofol—epilepsy syndrome	0.000184	0.00366	CcSEcCtD
Methamphetamine—Insomnia—Lacosamide—epilepsy syndrome	0.000184	0.00366	CcSEcCtD
Methamphetamine—Tremor—Midazolam—epilepsy syndrome	0.000183	0.00365	CcSEcCtD
Methamphetamine—SLC18A2—head—epilepsy syndrome	0.000182	0.0067	CbGeAlD
Methamphetamine—Tremor—Levetiracetam—epilepsy syndrome	0.000181	0.00361	CcSEcCtD
Methamphetamine—Agitation—Midazolam—epilepsy syndrome	0.00018	0.00358	CcSEcCtD
Methamphetamine—Dyspepsia—Lacosamide—epilepsy syndrome	0.000179	0.00356	CcSEcCtD
Methamphetamine—MAOA—forebrain—epilepsy syndrome	0.000178	0.00658	CbGeAlD
Methamphetamine—Insomnia—Clobazam—epilepsy syndrome	0.000178	0.00355	CcSEcCtD
Methamphetamine—SLC6A2—telencephalon—epilepsy syndrome	0.000178	0.00657	CbGeAlD
Methamphetamine—Agitation—Levetiracetam—epilepsy syndrome	0.000177	0.00354	CcSEcCtD
Methamphetamine—Headache—Primidone—epilepsy syndrome	0.000177	0.00353	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000175	0.0035	CcSEcCtD
Methamphetamine—Urticaria—Phenobarbital—epilepsy syndrome	0.000175	0.00349	CcSEcCtD
Methamphetamine—Tremor—Fosphenytoin—epilepsy syndrome	0.000175	0.00348	CcSEcCtD
Methamphetamine—Psychotic disorder—Pregabalin—epilepsy syndrome	0.000174	0.00348	CcSEcCtD
Methamphetamine—Constipation—Lacosamide—epilepsy syndrome	0.000174	0.00346	CcSEcCtD
Methamphetamine—SLC18A2—nervous system—epilepsy syndrome	0.000172	0.00635	CbGeAlD
Methamphetamine—Agitation—Fosphenytoin—epilepsy syndrome	0.000171	0.00342	CcSEcCtD
Methamphetamine—Tremor—Vigabatrin—epilepsy syndrome	0.00017	0.0034	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.00017	0.00339	CcSEcCtD
Methamphetamine—Constipation—Clobazam—epilepsy syndrome	0.000168	0.00336	CcSEcCtD
Methamphetamine—Agitation—Vigabatrin—epilepsy syndrome	0.000167	0.00333	CcSEcCtD
Methamphetamine—SLC18A2—central nervous system—epilepsy syndrome	0.000166	0.00612	CbGeAlD
Methamphetamine—Palpitations—Fosphenytoin—epilepsy syndrome	0.000165	0.00329	CcSEcCtD
Methamphetamine—Agitation—Diazepam—epilepsy syndrome	0.000164	0.00328	CcSEcCtD
Methamphetamine—MAOA—telencephalon—epilepsy syndrome	0.000164	0.00605	CbGeAlD
Methamphetamine—Euphoric mood—Topiramate—epilepsy syndrome	0.000163	0.00325	CcSEcCtD
Methamphetamine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000162	0.00324	CcSEcCtD
Methamphetamine—Tremor—Felbamate—epilepsy syndrome	0.000162	0.00324	CcSEcCtD
Methamphetamine—SLC18A2—cerebellum—epilepsy syndrome	0.000162	0.00598	CbGeAlD
Methamphetamine—Urticaria—Lacosamide—epilepsy syndrome	0.000161	0.00322	CcSEcCtD
Methamphetamine—Psychotic disorder—Gabapentin—epilepsy syndrome	0.00016	0.00319	CcSEcCtD
Methamphetamine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000159	0.00318	CcSEcCtD
Methamphetamine—Tachycardia—Propofol—epilepsy syndrome	0.000159	0.00318	CcSEcCtD
Methamphetamine—Agitation—Felbamate—epilepsy syndrome	0.000159	0.00317	CcSEcCtD
Methamphetamine—Tremor—Zonisamide—epilepsy syndrome	0.000159	0.00317	CcSEcCtD
Methamphetamine—SLC6A3—midbrain—epilepsy syndrome	0.000158	0.00584	CbGeAlD
Methamphetamine—Palpitations—Diazepam—epilepsy syndrome	0.000158	0.00315	CcSEcCtD
Methamphetamine—ADRA2C—telencephalon—epilepsy syndrome	0.000158	0.00582	CbGeAlD
Methamphetamine—Urticaria—Clobazam—epilepsy syndrome	0.000156	0.00312	CcSEcCtD
Methamphetamine—Headache—Trimethadione—epilepsy syndrome	0.000156	0.00311	CcSEcCtD
Methamphetamine—Tachycardia—Midazolam—epilepsy syndrome	0.000156	0.00311	CcSEcCtD
Methamphetamine—Agitation—Zonisamide—epilepsy syndrome	0.000156	0.00311	CcSEcCtD
Methamphetamine—SLC6A3—spinal cord—epilepsy syndrome	0.000155	0.0057	CbGeAlD
Methamphetamine—Dyspepsia—Acetazolamide—epilepsy syndrome	0.000155	0.00308	CcSEcCtD
Methamphetamine—Tremor—Clonazepam—epilepsy syndrome	0.000153	0.00305	CcSEcCtD
Methamphetamine—Palpitations—Felbamate—epilepsy syndrome	0.000153	0.00305	CcSEcCtD
Methamphetamine—Tremor—Phenytoin—epilepsy syndrome	0.000152	0.00303	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000152	0.00302	CcSEcCtD
Methamphetamine—Tremor—Oxcarbazepine—epilepsy syndrome	0.000151	0.00302	CcSEcCtD
Methamphetamine—MAOB—medulla oblongata—epilepsy syndrome	0.000151	0.00557	CbGeAlD
Methamphetamine—Agitation—Clonazepam—epilepsy syndrome	0.00015	0.00299	CcSEcCtD
Methamphetamine—Palpitations—Zonisamide—epilepsy syndrome	0.00015	0.00299	CcSEcCtD
Methamphetamine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00015	0.00298	CcSEcCtD
Methamphetamine—Agitation—Phenytoin—epilepsy syndrome	0.000149	0.00297	CcSEcCtD
Methamphetamine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000148	0.00296	CcSEcCtD
Methamphetamine—Agitation—Oxcarbazepine—epilepsy syndrome	0.000148	0.00296	CcSEcCtD
Methamphetamine—Diarrhoea—Rufinamide—epilepsy syndrome	0.000148	0.00295	CcSEcCtD
Methamphetamine—Insomnia—Propofol—epilepsy syndrome	0.000147	0.00294	CcSEcCtD
Methamphetamine—Lacosamide—SCN9A—epilepsy syndrome	0.000146	0.0778	CrCbGaD
Methamphetamine—Dizziness—Phenobarbital—epilepsy syndrome	0.000146	0.00291	CcSEcCtD
Methamphetamine—SLC6A4—midbrain—epilepsy syndrome	0.000145	0.00536	CbGeAlD
Methamphetamine—Tremor—Carbamazepine—epilepsy syndrome	0.000145	0.00289	CcSEcCtD
Methamphetamine—Palpitations—Clonazepam—epilepsy syndrome	0.000144	0.00288	CcSEcCtD
Methamphetamine—Palpitations—Phenytoin—epilepsy syndrome	0.000143	0.00286	CcSEcCtD
Methamphetamine—Dizziness—Rufinamide—epilepsy syndrome	0.000143	0.00285	CcSEcCtD
Methamphetamine—Palpitations—Oxcarbazepine—epilepsy syndrome	0.000143	0.00284	CcSEcCtD
Methamphetamine—Insomnia—Levetiracetam—epilepsy syndrome	0.000142	0.00284	CcSEcCtD
Methamphetamine—Tachycardia—Diazepam—epilepsy syndrome	0.000142	0.00284	CcSEcCtD
Methamphetamine—Agitation—Carbamazepine—epilepsy syndrome	0.000142	0.00284	CcSEcCtD
Methamphetamine—Erectile dysfunction—Pregabalin—epilepsy syndrome	0.000142	0.00283	CcSEcCtD
Methamphetamine—SLC6A4—spinal cord—epilepsy syndrome	0.000142	0.00523	CbGeAlD
Methamphetamine—Dyspepsia—Midazolam—epilepsy syndrome	0.00014	0.0028	CcSEcCtD
Methamphetamine—Tremor—Lamotrigine—epilepsy syndrome	0.00014	0.0028	CcSEcCtD
Methamphetamine—SLC6A2—medulla oblongata—epilepsy syndrome	0.00014	0.00516	CbGeAlD
Methamphetamine—Lacosamide—SCN3A—epilepsy syndrome	0.00014	0.0744	CrCbGaD
Methamphetamine—Urticaria—Acetazolamide—epilepsy syndrome	0.000139	0.00278	CcSEcCtD
Methamphetamine—Diarrhoea—Lacosamide—epilepsy syndrome	0.000139	0.00277	CcSEcCtD
Methamphetamine—Dyspepsia—Levetiracetam—epilepsy syndrome	0.000139	0.00277	CcSEcCtD
Methamphetamine—MAOB—midbrain—epilepsy syndrome	0.000138	0.00509	CbGeAlD
Methamphetamine—Headache—Phenobarbital—epilepsy syndrome	0.000138	0.00275	CcSEcCtD
Methamphetamine—Tachycardia—Felbamate—epilepsy syndrome	0.000138	0.00275	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.000138	0.00275	CcSEcCtD
Methamphetamine—Insomnia—Fosphenytoin—epilepsy syndrome	0.000138	0.00274	CcSEcCtD
Methamphetamine—Agitation—Lamotrigine—epilepsy syndrome	0.000137	0.00274	CcSEcCtD
Methamphetamine—SLC6A3—head—epilepsy syndrome	0.000137	0.00507	CbGeAlD
Methamphetamine—ADRA2A—forebrain—epilepsy syndrome	0.000137	0.00505	CbGeAlD
Methamphetamine—Constipation—Midazolam—epilepsy syndrome	0.000136	0.00272	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000136	0.00271	CcSEcCtD
Methamphetamine—Headache—Rufinamide—epilepsy syndrome	0.000135	0.0027	CcSEcCtD
Methamphetamine—Tachycardia—Zonisamide—epilepsy syndrome	0.000135	0.00269	CcSEcCtD
Methamphetamine—Diarrhoea—Clobazam—epilepsy syndrome	0.000135	0.00269	CcSEcCtD
Methamphetamine—Constipation—Levetiracetam—epilepsy syndrome	0.000135	0.00269	CcSEcCtD
Methamphetamine—MAOB—spinal cord—epilepsy syndrome	0.000135	0.00497	CbGeAlD
Methamphetamine—Psychotic disorder—Topiramate—epilepsy syndrome	0.000134	0.00268	CcSEcCtD
Methamphetamine—Dizziness—Lacosamide—epilepsy syndrome	0.000134	0.00268	CcSEcCtD
Methamphetamine—Insomnia—Vigabatrin—epilepsy syndrome	0.000134	0.00267	CcSEcCtD
Methamphetamine—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000134	0.00267	CcSEcCtD
Methamphetamine—Palpitations—Lamotrigine—epilepsy syndrome	0.000132	0.00264	CcSEcCtD
Methamphetamine—Insomnia—Diazepam—epilepsy syndrome	0.000132	0.00263	CcSEcCtD
Methamphetamine—SLC18A2—brain—epilepsy syndrome	0.000132	0.00486	CbGeAlD
Methamphetamine—Dyspepsia—Vigabatrin—epilepsy syndrome	0.00013	0.0026	CcSEcCtD
Methamphetamine—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.00013	0.0026	CcSEcCtD
Methamphetamine—Dizziness—Clobazam—epilepsy syndrome	0.00013	0.0026	CcSEcCtD
Methamphetamine—SLC6A3—nervous system—epilepsy syndrome	0.00013	0.0048	CbGeAlD
Methamphetamine—Tachycardia—Clonazepam—epilepsy syndrome	0.00013	0.00259	CcSEcCtD
Methamphetamine—Constipation—Fosphenytoin—epilepsy syndrome	0.00013	0.00259	CcSEcCtD
Methamphetamine—Urticaria—Propofol—epilepsy syndrome	0.00013	0.00258	CcSEcCtD
Methamphetamine—SLC22A3—head—epilepsy syndrome	0.000129	0.00477	CbGeAlD
Methamphetamine—Tachycardia—Phenytoin—epilepsy syndrome	0.000129	0.00258	CcSEcCtD
Methamphetamine—MAOA—medulla oblongata—epilepsy syndrome	0.000129	0.00475	CbGeAlD
Methamphetamine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000128	0.00256	CcSEcCtD
Methamphetamine—Dyspepsia—Diazepam—epilepsy syndrome	0.000128	0.00256	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000128	0.00255	CcSEcCtD
Methamphetamine—Insomnia—Felbamate—epilepsy syndrome	0.000128	0.00255	CcSEcCtD
Methamphetamine—Phenelzine—ABAT—epilepsy syndrome	0.000127	0.0679	CrCbGaD
Methamphetamine—Headache—Lacosamide—epilepsy syndrome	0.000127	0.00254	CcSEcCtD
Methamphetamine—Constipation—Vigabatrin—epilepsy syndrome	0.000127	0.00253	CcSEcCtD
Methamphetamine—Urticaria—Midazolam—epilepsy syndrome	0.000127	0.00253	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.000126	0.00251	CcSEcCtD
Methamphetamine—SLC6A4—head—epilepsy syndrome	0.000126	0.00464	CbGeAlD
Methamphetamine—ADRA2A—telencephalon—epilepsy syndrome	0.000126	0.00464	CbGeAlD
Methamphetamine—SLC6A3—central nervous system—epilepsy syndrome	0.000125	0.00463	CbGeAlD
Methamphetamine—Insomnia—Zonisamide—epilepsy syndrome	0.000125	0.00249	CcSEcCtD
Methamphetamine—Constipation—Diazepam—epilepsy syndrome	0.000125	0.00249	CcSEcCtD
Methamphetamine—Dyspepsia—Felbamate—epilepsy syndrome	0.000124	0.00248	CcSEcCtD
Methamphetamine—ADRA2C—medulla oblongata—epilepsy syndrome	0.000124	0.00457	CbGeAlD
Methamphetamine—Headache—Clobazam—epilepsy syndrome	0.000123	0.00246	CcSEcCtD
Methamphetamine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000123	0.00246	CcSEcCtD
Methamphetamine—SLC22A3—nervous system—epilepsy syndrome	0.000123	0.00452	CbGeAlD
Methamphetamine—SLC6A3—cerebellum—epilepsy syndrome	0.000123	0.00452	CbGeAlD
Methamphetamine—Dyspepsia—Zonisamide—epilepsy syndrome	0.000122	0.00243	CcSEcCtD
Methamphetamine—Urticaria—Fosphenytoin—epilepsy syndrome	0.000121	0.00241	CcSEcCtD
Methamphetamine—Constipation—Felbamate—epilepsy syndrome	0.000121	0.00241	CcSEcCtD
Methamphetamine—Insomnia—Clonazepam—epilepsy syndrome	0.00012	0.0024	CcSEcCtD
Methamphetamine—Diarrhoea—Acetazolamide—epilepsy syndrome	0.00012	0.0024	CcSEcCtD
Methamphetamine—Insomnia—Phenytoin—epilepsy syndrome	0.00012	0.00239	CcSEcCtD
Methamphetamine—MAOB—head—epilepsy syndrome	0.00012	0.00442	CbGeAlD
Methamphetamine—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000119	0.00238	CcSEcCtD
Methamphetamine—SLC6A4—nervous system—epilepsy syndrome	0.000119	0.0044	CbGeAlD
Methamphetamine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000119	0.00238	CcSEcCtD
Methamphetamine—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000119	0.00238	CcSEcCtD
Methamphetamine—SLC22A5—medulla oblongata—epilepsy syndrome	0.000119	0.00438	CbGeAlD
Methamphetamine—Constipation—Zonisamide—epilepsy syndrome	0.000118	0.00236	CcSEcCtD
Methamphetamine—SLC22A3—central nervous system—epilepsy syndrome	0.000118	0.00436	CbGeAlD
Methamphetamine—MAOA—midbrain—epilepsy syndrome	0.000118	0.00434	CbGeAlD
Methamphetamine—Urticaria—Vigabatrin—epilepsy syndrome	0.000118	0.00235	CcSEcCtD
Methamphetamine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000118	0.00235	CcSEcCtD
Methamphetamine—Dyspepsia—Clonazepam—epilepsy syndrome	0.000117	0.00234	CcSEcCtD
Methamphetamine—Dyspepsia—Phenytoin—epilepsy syndrome	0.000116	0.00232	CcSEcCtD
Methamphetamine—Dizziness—Acetazolamide—epilepsy syndrome	0.000116	0.00232	CcSEcCtD
Methamphetamine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000116	0.00232	CcSEcCtD
Methamphetamine—Urticaria—Diazepam—epilepsy syndrome	0.000116	0.00231	CcSEcCtD
Methamphetamine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000116	0.00231	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000115	0.0023	CcSEcCtD
Methamphetamine—SLC6A4—central nervous system—epilepsy syndrome	0.000115	0.00424	CbGeAlD
Methamphetamine—MAOA—spinal cord—epilepsy syndrome	0.000115	0.00424	CbGeAlD
Methamphetamine—Insomnia—Carbamazepine—epilepsy syndrome	0.000114	0.00228	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000114	0.00228	CcSEcCtD
Methamphetamine—Constipation—Clonazepam—epilepsy syndrome	0.000114	0.00227	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000114	0.00227	CcSEcCtD
Methamphetamine—MAOB—nervous system—epilepsy syndrome	0.000113	0.00419	CbGeAlD
Methamphetamine—ADRA2C—midbrain—epilepsy syndrome	0.000113	0.00418	CbGeAlD
Methamphetamine—Constipation—Phenytoin—epilepsy syndrome	0.000113	0.00226	CcSEcCtD
Methamphetamine—Constipation—Oxcarbazepine—epilepsy syndrome	0.000113	0.00225	CcSEcCtD
Methamphetamine—Urticaria—Felbamate—epilepsy syndrome	0.000112	0.00224	CcSEcCtD
Methamphetamine—Diarrhoea—Propofol—epilepsy syndrome	0.000112	0.00223	CcSEcCtD
Methamphetamine—Tremor—Valproic Acid—epilepsy syndrome	0.000111	0.00222	CcSEcCtD
Methamphetamine—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000111	0.00222	CcSEcCtD
Methamphetamine—SLC6A2—head—epilepsy syndrome	0.000111	0.00409	CbGeAlD
Methamphetamine—ADRA2C—spinal cord—epilepsy syndrome	0.00011	0.00408	CbGeAlD
Methamphetamine—Insomnia—Lamotrigine—epilepsy syndrome	0.00011	0.0022	CcSEcCtD
Methamphetamine—Headache—Acetazolamide—epilepsy syndrome	0.00011	0.00219	CcSEcCtD
Methamphetamine—Urticaria—Zonisamide—epilepsy syndrome	0.00011	0.00219	CcSEcCtD
Methamphetamine—CYP2D6—brainstem—epilepsy syndrome	0.00011	0.00405	CbGeAlD
Methamphetamine—Erectile dysfunction—Topiramate—epilepsy syndrome	0.00011	0.00219	CcSEcCtD
Methamphetamine—MAOB—central nervous system—epilepsy syndrome	0.000109	0.00403	CbGeAlD
Methamphetamine—Agitation—Valproic Acid—epilepsy syndrome	0.000109	0.00218	CcSEcCtD
Methamphetamine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000109	0.00218	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000109	0.00218	CcSEcCtD
Methamphetamine—SLC22A5—midbrain—epilepsy syndrome	0.000108	0.004	CbGeAlD
Methamphetamine—Constipation—Carbamazepine—epilepsy syndrome	0.000108	0.00216	CcSEcCtD
Methamphetamine—Dizziness—Propofol—epilepsy syndrome	0.000108	0.00215	CcSEcCtD
Methamphetamine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000108	0.00215	CcSEcCtD
Methamphetamine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000107	0.00215	CcSEcCtD
Methamphetamine—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000107	0.00214	CcSEcCtD
Methamphetamine—MAOB—cerebellum—epilepsy syndrome	0.000107	0.00394	CbGeAlD
Methamphetamine—CYP2D6—forebrain—epilepsy syndrome	0.000106	0.00391	CbGeAlD
Methamphetamine—Urticaria—Clonazepam—epilepsy syndrome	0.000106	0.00211	CcSEcCtD
Methamphetamine—SLC22A5—spinal cord—epilepsy syndrome	0.000106	0.0039	CbGeAlD
Methamphetamine—Dizziness—Midazolam—epilepsy syndrome	0.000105	0.00211	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000105	0.0021	CcSEcCtD
Methamphetamine—Urticaria—Phenytoin—epilepsy syndrome	0.000105	0.0021	CcSEcCtD
Methamphetamine—SLC6A2—nervous system—epilepsy syndrome	0.000105	0.00388	CbGeAlD
Methamphetamine—Palpitations—Valproic Acid—epilepsy syndrome	0.000105	0.0021	CcSEcCtD
Methamphetamine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000105	0.00209	CcSEcCtD
Methamphetamine—Constipation—Lamotrigine—epilepsy syndrome	0.000104	0.00208	CcSEcCtD
Methamphetamine—Dizziness—Levetiracetam—epilepsy syndrome	0.000104	0.00208	CcSEcCtD
Methamphetamine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000104	0.00208	CcSEcCtD
Methamphetamine—Headache—Propofol—epilepsy syndrome	0.000102	0.00204	CcSEcCtD
Methamphetamine—MAOA—head—epilepsy syndrome	0.000102	0.00377	CbGeAlD
Methamphetamine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000102	0.00203	CcSEcCtD
Methamphetamine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000101	0.00202	CcSEcCtD
Methamphetamine—SLC6A2—central nervous system—epilepsy syndrome	0.000101	0.00373	CbGeAlD
Methamphetamine—Tremor—Pregabalin—epilepsy syndrome	0.000101	0.00201	CcSEcCtD
Methamphetamine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000101	0.00201	CcSEcCtD
Methamphetamine—Urticaria—Carbamazepine—epilepsy syndrome	0.0001	0.002	CcSEcCtD
Methamphetamine—Headache—Midazolam—epilepsy syndrome	9.99e-05	0.00199	CcSEcCtD
Methamphetamine—Diarrhoea—Diazepam—epilepsy syndrome	9.98e-05	0.00199	CcSEcCtD
Methamphetamine—SLC6A3—brain—epilepsy syndrome	9.95e-05	0.00367	CbGeAlD
Methamphetamine—ADRA2A—medulla oblongata—epilepsy syndrome	9.88e-05	0.00365	CbGeAlD
Methamphetamine—Agitation—Pregabalin—epilepsy syndrome	9.87e-05	0.00197	CcSEcCtD
Methamphetamine—Headache—Levetiracetam—epilepsy syndrome	9.87e-05	0.00197	CcSEcCtD
Methamphetamine—ADRA2C—head—epilepsy syndrome	9.82e-05	0.00362	CbGeAlD
Methamphetamine—Hypersensitivity—Clonazepam—epilepsy syndrome	9.81e-05	0.00196	CcSEcCtD
Methamphetamine—Dizziness—Vigabatrin—epilepsy syndrome	9.8e-05	0.00196	CcSEcCtD
Methamphetamine—Hypersensitivity—Phenytoin—epilepsy syndrome	9.75e-05	0.00195	CcSEcCtD
Methamphetamine—CYP2D6—telencephalon—epilepsy syndrome	9.74e-05	0.0036	CbGeAlD
Methamphetamine—Urticaria—Lamotrigine—epilepsy syndrome	9.7e-05	0.00194	CcSEcCtD
Methamphetamine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	9.7e-05	0.00194	CcSEcCtD
Methamphetamine—MAOA—nervous system—epilepsy syndrome	9.68e-05	0.00357	CbGeAlD
Methamphetamine—Diarrhoea—Felbamate—epilepsy syndrome	9.66e-05	0.00193	CcSEcCtD
Methamphetamine—Dizziness—Diazepam—epilepsy syndrome	9.65e-05	0.00193	CcSEcCtD
Methamphetamine—L-Phenylalanine—TH—epilepsy syndrome	9.6e-05	0.0512	CrCbGaD
Methamphetamine—Headache—Fosphenytoin—epilepsy syndrome	9.52e-05	0.0019	CcSEcCtD
Methamphetamine—Palpitations—Pregabalin—epilepsy syndrome	9.5e-05	0.0019	CcSEcCtD
Methamphetamine—Tachycardia—Valproic Acid—epilepsy syndrome	9.47e-05	0.00189	CcSEcCtD
Methamphetamine—Diarrhoea—Zonisamide—epilepsy syndrome	9.46e-05	0.00189	CcSEcCtD
Methamphetamine—SLC22A3—brain—epilepsy syndrome	9.37e-05	0.00346	CbGeAlD
Methamphetamine—Dizziness—Felbamate—epilepsy syndrome	9.34e-05	0.00186	CcSEcCtD
Methamphetamine—MAOA—central nervous system—epilepsy syndrome	9.32e-05	0.00344	CbGeAlD
Methamphetamine—ADRA2C—nervous system—epilepsy syndrome	9.31e-05	0.00343	CbGeAlD
Methamphetamine—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.31e-05	0.00186	CcSEcCtD
Methamphetamine—Headache—Vigabatrin—epilepsy syndrome	9.28e-05	0.00185	CcSEcCtD
Methamphetamine—Tremor—Gabapentin—epilepsy syndrome	9.23e-05	0.00184	CcSEcCtD
Methamphetamine—Lacosamide—CA4—epilepsy syndrome	9.19e-05	0.049	CrCbGaD
Methamphetamine—Dizziness—Zonisamide—epilepsy syndrome	9.14e-05	0.00182	CcSEcCtD
Methamphetamine—Headache—Diazepam—epilepsy syndrome	9.14e-05	0.00182	CcSEcCtD
Methamphetamine—SLC6A4—brain—epilepsy syndrome	9.12e-05	0.00337	CbGeAlD
Methamphetamine—Diarrhoea—Clonazepam—epilepsy syndrome	9.11e-05	0.00182	CcSEcCtD
Methamphetamine—MAOA—cerebellum—epilepsy syndrome	9.11e-05	0.00336	CbGeAlD
Methamphetamine—Agitation—Gabapentin—epilepsy syndrome	9.05e-05	0.00181	CcSEcCtD
Methamphetamine—Diarrhoea—Phenytoin—epilepsy syndrome	9.05e-05	0.00181	CcSEcCtD
Methamphetamine—ADRA2A—midbrain—epilepsy syndrome	9.03e-05	0.00333	CbGeAlD
Methamphetamine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.01e-05	0.0018	CcSEcCtD
Methamphetamine—Hypersensitivity—Lamotrigine—epilepsy syndrome	8.99e-05	0.00179	CcSEcCtD
Methamphetamine—ADRA2C—central nervous system—epilepsy syndrome	8.96e-05	0.00331	CbGeAlD
Methamphetamine—Headache—Felbamate—epilepsy syndrome	8.85e-05	0.00177	CcSEcCtD
Methamphetamine—ADRA2A—spinal cord—epilepsy syndrome	8.81e-05	0.00325	CbGeAlD
Methamphetamine—Dizziness—Clonazepam—epilepsy syndrome	8.81e-05	0.00176	CcSEcCtD
Methamphetamine—Insomnia—Valproic Acid—epilepsy syndrome	8.77e-05	0.00175	CcSEcCtD
Methamphetamine—ADRA2C—cerebellum—epilepsy syndrome	8.76e-05	0.00323	CbGeAlD
Methamphetamine—Dizziness—Phenytoin—epilepsy syndrome	8.75e-05	0.00175	CcSEcCtD
Methamphetamine—Palpitations—Gabapentin—epilepsy syndrome	8.71e-05	0.00174	CcSEcCtD
Methamphetamine—Dizziness—Oxcarbazepine—epilepsy syndrome	8.7e-05	0.00174	CcSEcCtD
Methamphetamine—MAOB—brain—epilepsy syndrome	8.67e-05	0.0032	CbGeAlD
Methamphetamine—Headache—Zonisamide—epilepsy syndrome	8.66e-05	0.00173	CcSEcCtD
Methamphetamine—Diarrhoea—Carbamazepine—epilepsy syndrome	8.64e-05	0.00172	CcSEcCtD
Methamphetamine—Tachycardia—Pregabalin—epilepsy syndrome	8.56e-05	0.00171	CcSEcCtD
Methamphetamine—Dyspepsia—Valproic Acid—epilepsy syndrome	8.54e-05	0.0017	CcSEcCtD
Methamphetamine—SLC22A5—cerebellum—epilepsy syndrome	8.39e-05	0.0031	CbGeAlD
Methamphetamine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.37e-05	0.00167	CcSEcCtD
Methamphetamine—Dizziness—Carbamazepine—epilepsy syndrome	8.35e-05	0.00167	CcSEcCtD
Methamphetamine—Diarrhoea—Lamotrigine—epilepsy syndrome	8.35e-05	0.00167	CcSEcCtD
Methamphetamine—Headache—Clonazepam—epilepsy syndrome	8.34e-05	0.00167	CcSEcCtD
Methamphetamine—Constipation—Valproic Acid—epilepsy syndrome	8.29e-05	0.00166	CcSEcCtD
Methamphetamine—Headache—Phenytoin—epilepsy syndrome	8.29e-05	0.00165	CcSEcCtD
Methamphetamine—Headache—Oxcarbazepine—epilepsy syndrome	8.25e-05	0.00165	CcSEcCtD
Methamphetamine—Dizziness—Lamotrigine—epilepsy syndrome	8.07e-05	0.00161	CcSEcCtD
Methamphetamine—SLC6A2—brain—epilepsy syndrome	8.03e-05	0.00296	CbGeAlD
Methamphetamine—Insomnia—Pregabalin—epilepsy syndrome	7.93e-05	0.00158	CcSEcCtD
Methamphetamine—Headache—Carbamazepine—epilepsy syndrome	7.91e-05	0.00158	CcSEcCtD
Methamphetamine—Tachycardia—Gabapentin—epilepsy syndrome	7.85e-05	0.00157	CcSEcCtD
Methamphetamine—ADRA2A—head—epilepsy syndrome	7.83e-05	0.00289	CbGeAlD
Methamphetamine—Tremor—Topiramate—epilepsy syndrome	7.77e-05	0.00155	CcSEcCtD
Methamphetamine—Urticaria—Valproic Acid—epilepsy syndrome	7.71e-05	0.00154	CcSEcCtD
Methamphetamine—Headache—Lamotrigine—epilepsy syndrome	7.65e-05	0.00153	CcSEcCtD
Methamphetamine—Agitation—Topiramate—epilepsy syndrome	7.62e-05	0.00152	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.57e-05	0.00151	CcSEcCtD
Methamphetamine—Constipation—Pregabalin—epilepsy syndrome	7.5e-05	0.0015	CcSEcCtD
Methamphetamine—ADRA2A—nervous system—epilepsy syndrome	7.43e-05	0.00274	CbGeAlD
Methamphetamine—MAOA—brain—epilepsy syndrome	7.4e-05	0.00273	CbGeAlD
Methamphetamine—Palpitations—Topiramate—epilepsy syndrome	7.33e-05	0.00146	CcSEcCtD
Methamphetamine—Insomnia—Gabapentin—epilepsy syndrome	7.27e-05	0.00145	CcSEcCtD
Methamphetamine—ADRA2A—central nervous system—epilepsy syndrome	7.15e-05	0.00264	CbGeAlD
Methamphetamine—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.15e-05	0.00143	CcSEcCtD
Methamphetamine—ADRA2C—brain—epilepsy syndrome	7.11e-05	0.00262	CbGeAlD
Methamphetamine—Dyspepsia—Gabapentin—epilepsy syndrome	7.08e-05	0.00141	CcSEcCtD
Methamphetamine—ADRA2A—cerebellum—epilepsy syndrome	6.99e-05	0.00258	CbGeAlD
Methamphetamine—Urticaria—Pregabalin—epilepsy syndrome	6.97e-05	0.00139	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	6.94e-05	0.00139	CcSEcCtD
Methamphetamine—Nateglinide—KCNJ11—epilepsy syndrome	6.9e-05	0.0368	CrCbGaD
Methamphetamine—Constipation—Gabapentin—epilepsy syndrome	6.88e-05	0.00137	CcSEcCtD
Methamphetamine—Dexfenfluramine—SLC6A4—epilepsy syndrome	6.87e-05	0.0366	CrCbGaD
Methamphetamine—SLC22A5—brain—epilepsy syndrome	6.81e-05	0.00251	CbGeAlD
Methamphetamine—Diarrhoea—Valproic Acid—epilepsy syndrome	6.64e-05	0.00132	CcSEcCtD
Methamphetamine—Tachycardia—Topiramate—epilepsy syndrome	6.6e-05	0.00132	CcSEcCtD
Methamphetamine—Dexfenfluramine—CYP2C19—epilepsy syndrome	6.51e-05	0.0347	CrCbGaD
Methamphetamine—Hypersensitivity—Pregabalin—epilepsy syndrome	6.46e-05	0.00129	CcSEcCtD
Methamphetamine—Dizziness—Valproic Acid—epilepsy syndrome	6.41e-05	0.00128	CcSEcCtD
Methamphetamine—Urticaria—Gabapentin—epilepsy syndrome	6.39e-05	0.00127	CcSEcCtD
Methamphetamine—Insomnia—Topiramate—epilepsy syndrome	6.12e-05	0.00122	CcSEcCtD
Methamphetamine—Headache—Valproic Acid—epilepsy syndrome	6.08e-05	0.00121	CcSEcCtD
Methamphetamine—CYP2D6—head—epilepsy syndrome	6.07e-05	0.00224	CbGeAlD
Methamphetamine—Diarrhoea—Pregabalin—epilepsy syndrome	6e-05	0.0012	CcSEcCtD
Methamphetamine—Dyspepsia—Topiramate—epilepsy syndrome	5.95e-05	0.00119	CcSEcCtD
Methamphetamine—Hypersensitivity—Gabapentin—epilepsy syndrome	5.92e-05	0.00118	CcSEcCtD
Methamphetamine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.84e-05	0.00117	CcSEcCtD
Methamphetamine—Dizziness—Pregabalin—epilepsy syndrome	5.8e-05	0.00116	CcSEcCtD
Methamphetamine—Constipation—Topiramate—epilepsy syndrome	5.79e-05	0.00115	CcSEcCtD
Methamphetamine—CYP2D6—nervous system—epilepsy syndrome	5.75e-05	0.00212	CbGeAlD
Methamphetamine—ADRA2A—brain—epilepsy syndrome	5.68e-05	0.00209	CbGeAlD
Methamphetamine—Tolazoline—ADRA2A—epilepsy syndrome	5.57e-05	0.0297	CrCbGaD
Methamphetamine—CYP2D6—central nervous system—epilepsy syndrome	5.54e-05	0.00204	CbGeAlD
Methamphetamine—Diarrhoea—Gabapentin—epilepsy syndrome	5.5e-05	0.0011	CcSEcCtD
Methamphetamine—Headache—Pregabalin—epilepsy syndrome	5.49e-05	0.0011	CcSEcCtD
Methamphetamine—CYP2D6—cerebellum—epilepsy syndrome	5.41e-05	0.002	CbGeAlD
Methamphetamine—Urticaria—Topiramate—epilepsy syndrome	5.37e-05	0.00107	CcSEcCtD
Methamphetamine—Dizziness—Gabapentin—epilepsy syndrome	5.32e-05	0.00106	CcSEcCtD
Methamphetamine—Ephedrine—BCHE—epilepsy syndrome	5.3e-05	0.0283	CrCbGaD
Methamphetamine—Headache—Gabapentin—epilepsy syndrome	5.04e-05	0.00101	CcSEcCtD
Methamphetamine—Hypersensitivity—Topiramate—epilepsy syndrome	4.98e-05	0.000995	CcSEcCtD
Methamphetamine—Phenylpropanolamine—ADRA2A—epilepsy syndrome	4.86e-05	0.0259	CrCbGaD
Methamphetamine—Dexfenfluramine—CYP2D6—epilepsy syndrome	4.83e-05	0.0258	CrCbGaD
Methamphetamine—Diarrhoea—Topiramate—epilepsy syndrome	4.63e-05	0.000924	CcSEcCtD
Methamphetamine—Dizziness—Topiramate—epilepsy syndrome	4.47e-05	0.000893	CcSEcCtD
Methamphetamine—CYP2D6—brain—epilepsy syndrome	4.4e-05	0.00162	CbGeAlD
Methamphetamine—Headache—Topiramate—epilepsy syndrome	4.24e-05	0.000846	CcSEcCtD
Methamphetamine—Pseudoephedrine—ADRA2A—epilepsy syndrome	4.11e-05	0.0219	CrCbGaD
Methamphetamine—Pseudoephedrine—TNF—epilepsy syndrome	3.9e-05	0.0208	CrCbGaD
Methamphetamine—Phenformin—CYP2D6—epilepsy syndrome	3.4e-05	0.0181	CrCbGaD
Methamphetamine—Phentermine—SLC6A4—epilepsy syndrome	3.31e-05	0.0176	CrCbGaD
Methamphetamine—Pseudoephedrine—SLC6A4—epilepsy syndrome	3.14e-05	0.0167	CrCbGaD
Methamphetamine—Benzphetamine—ADRA2A—epilepsy syndrome	3.06e-05	0.0163	CrCbGaD
Methamphetamine—Selegiline—CYP2C19—epilepsy syndrome	2.9e-05	0.0155	CrCbGaD
Methamphetamine—Phenelzine—CYP2C19—epilepsy syndrome	2.56e-05	0.0136	CrCbGaD
Methamphetamine—Amphetamine—SLC6A4—epilepsy syndrome	2.54e-05	0.0136	CrCbGaD
Methamphetamine—Phentermine—CYP2D6—epilepsy syndrome	2.32e-05	0.0124	CrCbGaD
Methamphetamine—Benzyl alcohol—CYP2D6—epilepsy syndrome	2.24e-05	0.012	CrCbGaD
Methamphetamine—Dextroamphetamine—CYP2D6—epilepsy syndrome	2.22e-05	0.0118	CrCbGaD
Methamphetamine—Pseudoephedrine—CYP2D6—epilepsy syndrome	2.2e-05	0.0118	CrCbGaD
Methamphetamine—Selegiline—CYP2D6—epilepsy syndrome	2.15e-05	0.0115	CrCbGaD
Methamphetamine—Nateglinide—CYP2D6—epilepsy syndrome	1.92e-05	0.0103	CrCbGaD
Methamphetamine—Amphetamine—CYP2D6—epilepsy syndrome	1.79e-05	0.00953	CrCbGaD
Methamphetamine—Selegiline—ABCB1—epilepsy syndrome	1.54e-05	0.00819	CrCbGaD
Methamphetamine—Nateglinide—ALB—epilepsy syndrome	1.44e-05	0.00767	CrCbGaD
Methamphetamine—ADRA2B—Signaling Pathways—SST—epilepsy syndrome	1.81e-06	3.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NTRK2—epilepsy syndrome	1.81e-06	3.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR2—epilepsy syndrome	1.81e-06	3.18e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—HTR2A—epilepsy syndrome	1.81e-06	3.17e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ABCB1—epilepsy syndrome	1.8e-06	3.17e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—ALB—epilepsy syndrome	1.8e-06	3.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—DUSP6—epilepsy syndrome	1.79e-06	3.15e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADRA2A—epilepsy syndrome	1.77e-06	3.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PLAT—epilepsy syndrome	1.76e-06	3.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AVP—epilepsy syndrome	1.76e-06	3.09e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.76e-06	3.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.74e-06	3.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PTK2B—epilepsy syndrome	1.74e-06	3.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSC1—epilepsy syndrome	1.74e-06	3.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HRH3—epilepsy syndrome	1.74e-06	3.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—SRC—epilepsy syndrome	1.73e-06	3.04e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AGT—epilepsy syndrome	1.71e-06	3e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—OPRM1—epilepsy syndrome	1.71e-06	3e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.71e-06	3e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CXCL12—epilepsy syndrome	1.7e-06	2.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—BDKRB2—epilepsy syndrome	1.7e-06	2.99e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—POMC—epilepsy syndrome	1.7e-06	2.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—PRKCB—epilepsy syndrome	1.69e-06	2.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SST—epilepsy syndrome	1.69e-06	2.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NTRK2—epilepsy syndrome	1.69e-06	2.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR2—epilepsy syndrome	1.69e-06	2.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—VEGFA—epilepsy syndrome	1.69e-06	2.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CYP2D6—epilepsy syndrome	1.69e-06	2.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—IL6ST—epilepsy syndrome	1.69e-06	2.96e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—GPX1—epilepsy syndrome	1.68e-06	2.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—DUSP6—epilepsy syndrome	1.68e-06	2.94e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JUNB—epilepsy syndrome	1.67e-06	2.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CNR1—epilepsy syndrome	1.67e-06	2.93e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—POMC—epilepsy syndrome	1.67e-06	2.93e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PLCB1—epilepsy syndrome	1.66e-06	2.92e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADRA2A—epilepsy syndrome	1.65e-06	2.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	1.65e-06	2.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PLAT—epilepsy syndrome	1.65e-06	2.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR7—epilepsy syndrome	1.63e-06	2.86e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—SRC—epilepsy syndrome	1.62e-06	2.84e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	1.62e-06	2.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.61e-06	2.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	1.6e-06	2.81e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CXCL12—epilepsy syndrome	1.59e-06	2.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—BDKRB2—epilepsy syndrome	1.59e-06	2.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—POMC—epilepsy syndrome	1.59e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.59e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—PRKCB—epilepsy syndrome	1.58e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HBEGF—epilepsy syndrome	1.58e-06	2.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—VEGFA—epilepsy syndrome	1.58e-06	2.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—IL6ST—epilepsy syndrome	1.58e-06	2.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	1.57e-06	2.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	1.57e-06	2.76e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—PTGS2—epilepsy syndrome	1.57e-06	2.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JUNB—epilepsy syndrome	1.56e-06	2.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CNR1—epilepsy syndrome	1.56e-06	2.74e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PLCB1—epilepsy syndrome	1.55e-06	2.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT3—epilepsy syndrome	1.55e-06	2.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—HMOX1—epilepsy syndrome	1.55e-06	2.71e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.54e-06	2.71e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.54e-06	2.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—POMC—epilepsy syndrome	1.54e-06	2.71e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	1.53e-06	2.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	1.53e-06	2.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—CAT—epilepsy syndrome	1.53e-06	2.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR7—epilepsy syndrome	1.52e-06	2.67e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—ALB—epilepsy syndrome	1.52e-06	2.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	1.52e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	1.52e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	1.52e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	1.52e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	1.52e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—ADAM10—epilepsy syndrome	1.52e-06	2.66e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	1.51e-06	2.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—CCL2—epilepsy syndrome	1.51e-06	2.65e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—TH—epilepsy syndrome	1.51e-06	2.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	1.5e-06	2.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ABCB1—epilepsy syndrome	1.48e-06	2.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HBEGF—epilepsy syndrome	1.48e-06	2.59e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AGT—epilepsy syndrome	1.47e-06	2.58e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	1.47e-06	2.57e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT3—epilepsy syndrome	1.45e-06	2.54e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—POMC—epilepsy syndrome	1.44e-06	2.53e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—APOE—epilepsy syndrome	1.44e-06	2.53e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	1.43e-06	2.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	1.42e-06	2.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	1.42e-06	2.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—ADAM10—epilepsy syndrome	1.42e-06	2.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.42e-06	2.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	1.41e-06	2.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	1.41e-06	2.48e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—CCL2—epilepsy syndrome	1.41e-06	2.47e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	1.39e-06	2.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—GPX1—epilepsy syndrome	1.38e-06	2.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	1.37e-06	2.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	1.37e-06	2.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	1.37e-06	2.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	1.37e-06	2.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	1.36e-06	2.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	1.34e-06	2.35e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	1.34e-06	2.35e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—PTGS2—epilepsy syndrome	1.33e-06	2.34e-05	CbGpPWpGaD
Methamphetamine—TAAR1—Signaling Pathways—AKT1—epilepsy syndrome	1.33e-06	2.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	1.33e-06	2.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	1.32e-06	2.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	1.32e-06	2.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	1.3e-06	2.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	1.29e-06	2.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	1.29e-06	2.27e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	1.29e-06	2.26e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	1.29e-06	2.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	1.28e-06	2.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	1.28e-06	2.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	1.28e-06	2.25e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	1.27e-06	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	1.27e-06	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	1.26e-06	2.22e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	1.26e-06	2.21e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.26e-06	2.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	1.26e-06	2.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	1.26e-06	2.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	1.25e-06	2.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—CAT—epilepsy syndrome	1.24e-06	2.17e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—POMC—epilepsy syndrome	1.24e-06	2.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	1.24e-06	2.17e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.23e-06	2.15e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.22e-06	2.14e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.21e-06	2.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	1.21e-06	2.13e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AGT—epilepsy syndrome	1.21e-06	2.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	1.21e-06	2.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	1.2e-06	2.11e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	1.2e-06	2.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—APOE—epilepsy syndrome	1.19e-06	2.08e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	1.18e-06	2.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	1.18e-06	2.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	1.17e-06	2.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	1.17e-06	2.06e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	1.17e-06	2.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	1.17e-06	2.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.15e-06	2.02e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.15e-06	2.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	1.14e-06	2e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	1.13e-06	1.99e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—ALB—epilepsy syndrome	1.13e-06	1.98e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	1.12e-06	1.97e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	1.12e-06	1.96e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	1.09e-06	1.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.09e-06	1.91e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	1.08e-06	1.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	1.08e-06	1.9e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	1.08e-06	1.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.08e-06	1.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.08e-06	1.89e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.07e-06	1.87e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	1.06e-06	1.86e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.05e-06	1.84e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.04e-06	1.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.04e-06	1.83e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	1.04e-06	1.82e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—POMC—epilepsy syndrome	1.02e-06	1.79e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	1.01e-06	1.78e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	1.01e-06	1.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	1.01e-06	1.77e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	1e-06	1.76e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	9.97e-07	1.75e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	9.95e-07	1.75e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	9.91e-07	1.74e-05	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—PTGS2—epilepsy syndrome	9.88e-07	1.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	9.84e-07	1.73e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.84e-07	1.73e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AGT—epilepsy syndrome	9.83e-07	1.72e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—TH—epilepsy syndrome	9.81e-07	1.72e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	9.71e-07	1.7e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—APOE—epilepsy syndrome	9.63e-07	1.69e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	9.57e-07	1.68e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	9.54e-07	1.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	9.52e-07	1.67e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	9.35e-07	1.64e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	9.31e-07	1.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—ALB—epilepsy syndrome	9.29e-07	1.63e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	9.2e-07	1.61e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	9.12e-07	1.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	9.1e-07	1.6e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	8.92e-07	1.56e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	8.85e-07	1.55e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	8.66e-07	1.52e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	8.52e-07	1.49e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	8.33e-07	1.46e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—POMC—epilepsy syndrome	8.27e-07	1.45e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	8.23e-07	1.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	8.22e-07	1.44e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	8.19e-07	1.44e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	8.18e-07	1.43e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	8.12e-07	1.42e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—CAT—epilepsy syndrome	8.08e-07	1.42e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	8.06e-07	1.41e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	8.05e-07	1.41e-05	CbGpPWpGaD
Methamphetamine—MAOB—Metabolism—AKT1—epilepsy syndrome	7.91e-07	1.39e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	7.89e-07	1.38e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.86e-07	1.38e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	7.59e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	7.56e-07	1.33e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—ALB—epilepsy syndrome	7.54e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	7.53e-07	1.32e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	7.48e-07	1.31e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	7.34e-07	1.29e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	7.3e-07	1.28e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	6.99e-07	1.23e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	6.92e-07	1.21e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	6.86e-07	1.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	6.81e-07	1.2e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	6.77e-07	1.19e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	6.75e-07	1.18e-05	CbGpPWpGaD
Methamphetamine—SLC22A3—Metabolism—AKT1—epilepsy syndrome	6.69e-07	1.17e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	6.6e-07	1.16e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	6.56e-07	1.15e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.4e-07	1.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	6.38e-07	1.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	6.36e-07	1.12e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	6.31e-07	1.11e-05	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—APOE—epilepsy syndrome	6.28e-07	1.1e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	6.19e-07	1.09e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	6.12e-07	1.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	6.12e-07	1.07e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	5.96e-07	1.05e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	5.88e-07	1.03e-05	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	5.78e-07	1.01e-05	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	5.73e-07	1e-05	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	5.68e-07	9.96e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	5.57e-07	9.77e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	5.49e-07	9.64e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.39e-07	9.46e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	5.35e-07	9.39e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	5.17e-07	9.07e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	5.12e-07	8.98e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	4.97e-07	8.73e-06	CbGpPWpGaD
Methamphetamine—MAOA—Metabolism—AKT1—epilepsy syndrome	4.96e-07	8.71e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.91e-07	8.62e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	4.84e-07	8.49e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	4.69e-07	8.23e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	4.46e-07	7.83e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	4.35e-07	7.62e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.3e-07	7.54e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	4.08e-07	7.16e-06	CbGpPWpGaD
Methamphetamine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	3.65e-07	6.41e-06	CbGpPWpGaD
Methamphetamine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	3.41e-07	5.99e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	3.32e-07	5.82e-06	CbGpPWpGaD
Methamphetamine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	2.77e-07	4.86e-06	CbGpPWpGaD
Methamphetamine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.16e-07	3.79e-06	CbGpPWpGaD
